Kathleen Goetz, Director of Aurinia Pharmaceuticals AUPH, has filed 4 purchases and 0 sales on the open market. The latest trade was on 06/04.

KG

KG

Kathleen Goetz

Director

Company

Aurinia Pharmaceuticals AUPH

First filing

24/04/12

Trades

6 trades

Buys / sales

4 / 0

12-month net buying

No record

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
abrdn Healthcare InvestorsHQH	Open-market buy	24/04/09	24/04/12	525 sh	$16.42	$8,620.5	+94.7%
abrdn Life Sciences InvestorsHQL	Open-market buy	24/04/09	24/04/12	400 sh	$13.32	$5,328	+58.4%
abrdn Healthcare Opportunities FundTHQ	Open-market buy	24/04/09	24/04/12	600 sh	$19.54	$11,724	+109.5%
abrdn World Healthcare FundTHW	Open-market buy	24/04/09	24/04/12	200 sh	$12.53	$2,506	+24.5%